SOBI.ST - Swedish Orphan Biovitrum AB (publ)

Stockholm - Stockholm Real-time price. Currency in SEK
Currency in SEK

Valuation measures4

Market cap (intra-day) 73.98B
Enterprise value 83.01B
Trailing P/E 23.60
Forward P/E 20.28
PEG ratio (5-yr expected) 1.92
Price/sales (ttm)3.90
Price/book (mrq)2.66
Enterprise value/revenue 4.35
Enterprise value/EBITDA 12.04

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 311.84%
S&P500 52-week change 31.77%
52-week high 3273.80
52-week low 3199.10
50-day moving average 3247.92
200-day moving average 3229.57

Share statistics

Avg vol (3-month) 3347.68k
Avg vol (10-day) 3293.8k
Shares outstanding 5296.61M
Implied shares outstanding 6N/A
Float 8188.35M
% held by insiders 14.01%
% held by institutions 170.43%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)31 Mar 2023

Profitability

Profit margin 16.55%
Operating margin (ttm)23.96%

Management effectiveness

Return on assets (ttm)5.57%
Return on equity (ttm)12.26%

Income statement

Revenue (ttm)19.1B
Revenue per share (ttm)64.57
Quarterly revenue growth (yoy)6.40%
Gross profit (ttm)14.38B
EBITDA 6.76B
Net income avi to common (ttm)3.16B
Diluted EPS (ttm)10.34
Quarterly earnings growth (yoy)96.50%

Balance sheet

Total cash (mrq)198M
Total cash per share (mrq)0.67
Total debt (mrq)9.23B
Total debt/equity (mrq)33.18
Current ratio (mrq)0.70
Book value per share (mrq)93.82

Cash flow statement

Operating cash flow (ttm)5B
Levered free cash flow (ttm)-456.12M